TRAV2 and primary cutaneous T-cell non-Hodgkin lymphoma: Consistent with neoplastic cells previously described in advanced CTCL, CD4+ T cells from these clusters showed a dominant clonotype (TRBV7-2 and TRAV2) and apparent copy number variations [9, 18] (Figs. 1D, E).